Publications by authors named "Ana Sabsil Lopez Rocha"

Background: This systematic review analyzes the impact of COVID-19 on dementia patients' functional, cognitive, neuropsychiatric, and health related outcomes. It hypothesizes that dementia patients infected with SARS-CoV-2experience more pronounced deterioration compared to those who are uninfected.

Methods: Research from 01/03/2020 to 07/10/2023 was conducted using Medline, Web of Science, and Embase databases, and adhering to PRISMA guidelines and the PICO framework.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has seriously affected older adults' social lives, physical activity, and cognitive functions. Additionally, the lockdowns have disrupted regular healthcare for patients with chronic illnesses or needing acute care. Furthermore, the pandemic has negatively affected different psychosocial influences in each country due to the various cultural characteristics, technology, health system, and financial opportunities.

View Article and Find Full Text PDF

Subjective cognitive complaints (SCC) is a self-reported experience of persistently impaired cognitive functions which could be the earliest red flag of neurocognitive disorders. The COVID-19 pandemic and related restriction measures changed the lifestyle and behaviour of older adults. The aim of this study was to assess the relation of these changes and SCC status in Hungary.

View Article and Find Full Text PDF
Article Synopsis
  • This systematic review and meta-analysis aimed to assess the prevalence of thirteen neurological issues in COVID-19 patients during and after the acute phase of the illness, with follow-ups at 3, 6, 9, and 12 months.
  • The study analyzed data from 126 eligible studies with over 1.5 million COVID-19 subjects, focusing on neurological symptoms like fatigue, cognitive impairment, and anosmia, among others.
  • Results showed that during the acute phase, the most common neurological symptoms were anosmia/hyposmia, fatigue, and headaches, with some symptoms like fatigue and cognitive impairment remaining significant even at the 3-month follow-up.
View Article and Find Full Text PDF